<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00599144</url>
  </required_header>
  <id_info>
    <org_study_id>usl8</org_study_id>
    <nct_id>NCT00599144</nct_id>
  </id_info>
  <brief_title>Effectiveness of Bupivacaine After Laparoscopic Cholecystectomy</brief_title>
  <official_title>Effectiveness for Postoperative Pain After Laparoscopic Cholecystectomy of 0,5% Bupivacaine-Soaked Tabotamp Placed in the Gallbladder Bed</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Santa Maria alla Gruccia Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Santa Maria alla Gruccia Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the efficacy on postoperative pain of the positioning of a 0,5% bupivacaine
      soaked-tabotamp in gallbladder bed after videolaparoscopic cholecystectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain at 6 and 24 hours after surgery measured using the Visual Analogue Scale [VAS] [score 0 to 10, 0 = no pain, 10 = unbearable pain],</measure>
    <time_frame>6 and 24 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of analgesics, extension of postsurgery hospitalization, post operative nausea and vomiting.</measure>
    <time_frame>6 and 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group1: a bupivacaine 0,5% (2mg/kg) soaked-tabotamp is placed in gallbladder bed after remove of gallbladder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group2: bupivacaine 0,5%(2mg/kg)is infiltrated in trocar incision after their closure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Group3: control group without any local anesthetic use.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>videolaparocholecystectomy</intervention_name>
    <description>Group1: a bupivacaine 0,5% (2mg/kg) soaked-tabotamp is placed in gallbladder bed after remove of gallbladder</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>videolaparocholecystectomy</intervention_name>
    <description>Group2: bupivacaine 0,5%(2mg/kg)is infiltrated in trocar incision after their closure.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>videolaparocholecystectomy</intervention_name>
    <description>Group3: control group without any local anesthetic use.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18 years old, ASA 1 and 2

          -  Gallbladder adenomatous polyposis and cholelithiasis with no byochemical, clinical and
             instrumental evidence of acute cholecystitis at the moment of surgery.

        Exclusion Criteria:

          -  Age&lt;18 years old

          -  Pregnancy

          -  Previous major surgery of the supramesocholic compartment

          -  Acute cholecystitis

          -  Choledocolitiasis

          -  Acute pancreatitis at the moment of surgery

          -  Laparotomic conversion during surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Scatizzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Santa maria alla gruccia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale santa maria alla gruccia</name>
      <address>
        <city>Montevarchi</city>
        <state>Ar</state>
        <zip>52100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Verma GR, Lyngdoh TS, Kaman L, Bala I. Placement of 0.5% bupivacaine-soaked Surgicel in the gallbladder bed is effective for pain after laparoscopic cholecystectomy. Surg Endosc. 2006 Oct;20(10):1560-4. Epub 2006 Aug 1.</citation>
    <PMID>16897291</PMID>
  </reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2008</study_first_submitted>
  <study_first_submitted_qc>January 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2008</study_first_posted>
  <last_update_submitted>January 22, 2008</last_update_submitted>
  <last_update_submitted_qc>January 22, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2008</last_update_posted>
  <responsible_party>
    <name_title>Marco Scatizzi MD</name_title>
    <organization>Asl 8 santa maria alla gruccia hospital</organization>
  </responsible_party>
  <keyword>Cholecystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

